Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan, moxonidine, low-sodium diet, and placebo crossover study in formerly pre-eclamptic women
NL-OMON44513Not yet recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of losartan and moxonidine in hypertension (HTN) (4 arms), sponsored by University Medical Center Utrecht. Primary endpoints: Mean 24-hour systolic blood pressure, Mean 24-hour diastolic blood pressure and 4 more. Planned start Sep 2014; status: not yet recruiting.
02
Drugs
losartanmoxonidine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NL-OMON44513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44513.